Europe Artificial Organs and Bionic Implants Market - Growth, Trends, COVID-19 Impact, and Forecasts (2021 - 2026)

The Europe Artificial Organs and Bionic Implants market are segmented by is segmented By Type (Artificial Organs and Bionics) and Geography

Market Snapshot

Study Period: 2018 - 2026
Base Year: 2019
CAGR: 3.2 %

Need a report that reflects how COVID-19 has impacted this market and its growth?

Market Overview

The Europe Artificial Organs & Bionic Implants Market is expected to grow with a CAGR of 3.2% in the forecast period. The growth of the market in the country can be attributed to the increasing incidence of disabilities, organ failures, and scarcity of donor organs.

Moreover, the rising prevalence of renal disorders, acute renal failure, and the increase in organ failure due to the aging population are some more factors driving the market in this region. rapid involvement in the field of biomedical science has enabled organ transplantation a common practice. According to the estimates of the British Heart Foundation, in 2018, there were around 7 million people living with heart and circulatory diseases in the United Kingdom, and healthcare costs relating to the heart and circulatory diseases were estimated at GBP 9 billion each year. Therefore the increasing prevalence of chronic diseases helps in fueling the demand for artificial organs and bionics. In addition, development in bionic orthopedics, bionic eye, and exoskeleton is fueling the market growth.

Scope of the report

As per the scope of the report, artificial organs and bionics are man-made devices that can be implanted or integrated with humans, to either replace a natural organ or provide support for the purpose of restoring specific function or a group of related functions, helping the patient to return to his normal life.

By Product
Artificial Organs
Artificial Heart
Artificial Kidney
Cochlear Implants
Vision Bionics
Ear Bionics
Orthopedic Bionic
Cardiac Bionics
United Kingdom
Rest of Europe

Report scope can be customized per your requirements. Click here.

Key Market Trends

Cardiac Bionics Segment is Expected to Have a High Growth Rate During the Forecast Period

Cardiac bionics consist of heart valves, ventricular assisted devices, pacemakers, others. The high growth rate of the segment is attributed to the increasing prevalence of cardiovascular diseases, increasing geriatric population in the country. According to European Heart Network, each year cardiovascular disease (CVD) causes 3.9 million deaths in Europe and over 1.8 million deaths in the European Union. Death rates from both ischaemic heart disease (IHD) and stroke are generally higher in Central and Eastern Europe than in Northern, Southern, and Western Europe. CVD causes 46 times the number of deaths and 11 times the disease burden caused by AIDS, tuberculosis, and malaria combined in Europe. Therefore with this huge patient population, the demand for cardiac bionics and artificial heart is expected to rise in the forecast period.

europe cardio

Competitive Landscape

The Europe Artificial Organs & Bionic Implants Market is moderately competitive with several major players. Some of the strategies implemented include agreements, collaborative models, business expansion, and product developments. Most of the market players are focusing on bringing technologically advanced products in the market to acquire the maximum market share.

Table of Contents


    1. 1.1 Study Deliverables

    2. 1.2 Study Assumptions

    3. 1.3 Scope of the Study




    1. 4.1 Market Overview

    2. 4.2 Market Drivers

      1. 4.2.1 Increased Incidence of Disabilities, Organ Failures and Scarcity of Donor Organs

      2. 4.2.2 Technological Advancements Leading to Enhanced Applications

    3. 4.3 Market Restraints

      1. 4.3.1 Expensive Procedures and Fear of Device Malfunction and its Consequences

    4. 4.4 Porter's Five Force Analysis

      1. 4.4.1 Threat of New Entrants

      2. 4.4.2 Bargaining Power of Buyers/Consumers

      3. 4.4.3 Bargaining Power of Suppliers

      4. 4.4.4 Threat of Substitute Products

      5. 4.4.5 Intensity of Competitive Rivalry


    1. 5.1 By Product

      1. 5.1.1 Artificial Organs

        1. Artificial Heart

        2. Artificial Kidney

        3. Cochlear Implants

        4. Others

      2. 5.1.2 Bionics

        1. Vision Bionics

        2. Ear Bionics

        3. Orthopedic Bionic

        4. Cardiac Bionics

        5. Others

    2. 5.2 Geography

      1. 5.2.1 Europe

        1. Germany

        2. United Kingdom

        3. France

        4. Italy

        5. Spain

        6. Rest of Europe


    1. 6.1 Company Profiles

      1. 6.1.1 Boston Scientific Corporation

      2. 6.1.2 Otto Bock Holding GmbH & Co. KG

      3. 6.1.3 Medtronic plc

      4. 6.1.4 Zimmer Biomet

      5. 6.1.5 Sonova Holding AG (Advanced Bionics)

      6. 6.1.6 Edwards Lifesciences Corporation

      7. 6.1.7 Terumo Medical Corporation

      8. 6.1.8 OSSUR

    2. *List Not Exhaustive

**Subject to Availability
**Competitive Landscape covers- Business Overview, Financials, Products and Strategies and Recent Developments

You can also purchase parts of this report. Do you want to check out a section wise price list?

Frequently Asked Questions

The Europe Artificial Organs and Bionic Implants Market market is studied from 2018 - 2026.

The Europe Artificial Organs and Bionic Implants Market is growing at a CAGR of 3.2% over the next 5 years.

Boston Scientific Corporation, Medtronic plc, Zimmer Biomet, Sonova Holding AG(Advanced Bionics), Otto Bock Holding GmbH & Co. KG are the major companies operating in Europe Artificial Organs and Bionic Implants Market.

80% of our clients seek made-to-order reports. How do you want us to tailor yours?

Please enter a valid email id!

Please enter a valid message!